Stratification analysis of HOMA-IR in participant with insulin resistance and normal participant
INSULIN RESISTANCE
The effectiveness of CLM on improving insulin resistance against participant with insulin resistance (HOMA-IR > 1.66) was validated compared with normal participant (HOMA-IR < 1.66) as shown in Fig. Effect of CLM against insulin resistance (Further statistical analysis revealed that participants with decreased HbA1c with reduced markers (FBG, insulin, C-peptide, HOMA-IR, HOMA-IR) were more distributed in the CLM intake group (50%) than the placebo group (36.1%) (Table S